Aclarion Warrant (ACONW)

• Market cap: $43K
• 1 day: -17.62%
• 5 days: -32.81%
• 1 month: -40.77%
• 3 months: -43.86%
• 6 months: -40.11%
• Year to date: -15.69%
• 1 year: -34.85%
• 5 years: -97.06%
• 10 years: -97.06%
• Sector: Healthcare
• Industry: Health Information Services

About: Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Employees: 6

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.73% less ownership

Funds ownership: 1.99% [Q4 2024] → 1.26% (-0.73%) [Q1 2025]

4% less capital invested

Capital invested by funds: $4.12K [Q4 2024] → $3.96K (-$160) [Q1 2025]

20% less funds holding

Funds holding: 5 [Q4 2024] → 4 (-1) [Q1 2025]

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2